Changes in Melanocyte RNA and DNA Methylation Favor

Changes in Melanocyte RNA and DNA Methylation Favor

1 1 Changes in melanocyte RNA and DNA methylation favor 2 pheomelanin synthesis and may avoid systemic oxidative 3 stress after dietary cysteine supplementation in birds 4 Running title: Epigenetics of pheomelanin-based pigmentation 5 6 Sol Rodríguez-Martínez1, Rafael Márquez1, Ângela Inácio2 and 7 Ismael Galván1 8 9 1Departamento de Ecología Evolutiva, Estación Biológica de Doñana, CSIC, Sevilla, 10 Spain 11 2Laboratório de Genética, Instituto de Saúde Ambiental, Faculdade de Medicina, 12 Universidade de Lisboa, Lisboa, Portugal 13 14 Correspondence 15 Ismael Galván, Departamento de Ecología Evolutiva, Estación Biológica de Doñana, 16 CSIC, Sevilla, Spain. 17 Email: [email protected] 18 19 20 21 22 2 23 Abstract 24 Cysteine plays essential biological roles, but excessive amounts produce cellular 25 oxidative stress. Cysteine metabolism is mainly mediated by the enzymes cysteine 26 dioxygenase and γ-glutamylcysteine synthetase, respectively coded by the genes 27 CDO1 and GCLC. Here we test a new hypothesis posing that the synthesis of the 28 pigment pheomelanin also contributes to cysteine homeostasis in melanocytes, 29 where cysteine can enter the pheomelanogenesis pathway. We conducted a 30 experiment in the Eurasian nuthatch Sitta europaea, a bird producing large amounts 31 of pheomelanin for feather pigmentation, to investigate if melanocytes show 32 epigenetic lability under exposure to excess cysteine. We increased systemic 33 cysteine levels in nuthatches by supplementing them with dietary cysteine during 34 growth. This caused in feather melanocytes the downregulation of genes involved in 35 intracellular cysteine metabolism (GCLC), cysteine transport to the cytosol from the 36 extracellular medium (Slc7a11) and from melanosomes (CTNS), and regulation of 37 tyrosinase activity (MC1R and ASIP). These changes were mediated by increases in 38 DNA m5C in all genes excepting Slc7a11, which experienced RNA m6A depletion. 39 Birds supplemented with cysteine synthesized more pheomelanin than controls, but 40 did not suffer higher systemic oxidative stress. These results suggest that excess 41 cysteine activates an epigenetic mechanism that favors pheomelanin synthesis and 42 may protect from oxidative stress. 43 44 KEYWORDS 45 cysteine homeostasis, epigenetic mechanisms, gene expression, melanocytes, 46 methylation, pheomelanin-based pigmentation 3 47 1. INTRODUCTION 48 Cysteine is a semi-essential amino acid that cells metabolize to produce glutathione 49 (GSH), the major cellular antioxidant (1). Cysteine metabolism also leads to the 50 production of another amino acid, cysteinesulfinate, which is further converted to 51 either taurine or pyruvate and inorganic sulfur (2). These metabolites play a role in 52 several essential cellular processes, ranging from energy supplementation to 53 antioxidant protection (3,4). However, excess cysteine can occur when cysteine 54 availability is above the rate of cysteine metabolism, which favors the autooxidation 55 to the disulfide (cystine), a redox cycling that generates reactive oxygen species 56 (ROS) and thus produces oxidative stress (5). As a consequence, excess cysteine is 57 responsible for several, often lethal oxidative stress-based cytotoxic effects (6,7). 58 The maintenance of cysteine homeostasis is mainly mediated by two enzymes 59 that compete for cysteine as a substrate: cysteine dioxygenase (CDO), which 60 catalyzes the addition of molecular oxygen to the sulfhydryl group of cysteine to form 61 cysteinesulfinate, and γ-glutamylcysteine synthetase (GCS), which catalyzes the 62 rate-limiting step in GSH synthesis consisting in the binding of cysteine to glutamate 63 (2,8). CDO and GCS are therefore essential enzymes in the maintenance of cysteine 64 homeostasis. In spite of this process, CDO and GCS activity does not seem sufficient 65 to avoid the occurrence of excess cysteine. This is shown by the fact that a 66 dysfunction in cystinosin, a cystine/H+ symporter that exports cystine out of 67 lysosomes, causes intralysosomal excess cysteine and corresponding disease 68 (cystinosis) despite apparent functionality of CDO and GCS (9). Cystinosin can thus 69 be considered another essential component for the maintenance of cysteine 70 homeostasis (Figure 1). 4 71 In addition to CDO, GCS and cystinosin, another mechanism of cysteine 72 homeostasis specific to melanocytes has recently been proposed. Melanocytes are 73 cells that contain lysosome-like organelles, termed melanosomes, where the 74 synthesis of melanin pigments takes place (10). Melanin synthesis consists in the 75 oxidation of the amino acid tyrosine and the polymerization of the resulting indole 76 compounds. If intramelanosomal cysteine concentration is above a certain threshold, 77 kinetic conditions favor the incorporation of the sulfhydryl group of cysteine to the 78 reaction, which results in the formation of sulfur-containing heterocycles, reddish or 79 yellowish pigments that are termed pheomelanins (11). Pheomelanin is then 80 transferred to surrounding keratinocytes, thus confering pigmentation to the skin and 81 associated structures such as hair, feathers and scales (10). Therefore, cysteine 82 used in pheomelanin synthesis cannot be incorporated back into cysteine 83 metabolism, which means that the production of large amounts of pheomelanin in 84 melanocytes can lead to chronic systemic oxidative stress if cysteine is limiting 85 because sufficient GSH cannot be produced (12,13). This could actually explain the 86 increased risk of melanoma observed in humans and mice expressing phenotypes 87 that result from a high pheomelanin production (14,15), or the diminished antioxidant 88 capacity observed in wild birds exposed to ionizing radiation that pigment their 89 feathers with large amounts of pheomelanin (16). However, under the absence of 90 environmental factors that induce oxidative stress and make cysteine limiting, 91 pheomelanin synthesis may represent a form of cysteine excretion, thus helping to 92 avoid excess cysteine. Accordingly, pheomelanin synthesis has been proposed as a 93 mechanism contributing to cysteine homeostasis (17). In sum, there is a potential 94 physiological trade-off between the use of cysteine for pheomelanin synthesis and its 5 95 use for GSH synthesis, and the outcome of this trade-off can be determined by 96 environmental oxidative stress. 97 The functionality of pheomelanin-producing melanocytes in the context of 98 excess cysteine avoidance remains unexplored. If such function is physiologically 99 advantageous, we hypothesized that melanocytes would favor pheomelanin 100 synthesis under an increase in cysteine availability. Here we investigate this 101 possibility by experimentally increasing the dietary uptake of cysteine to developing 102 Eurasian nuthatches Sitta europaea, a passerine bird that deposits large amounts of 103 pheomelanin in flank feathers (18). Specifically, we tested if melanocytes from 104 growing pheomelanin-pigmented feathers show epigenetic lability and respond to the 105 increment in cysteine availability with a genetic favoring of pheomelanin synthesis. 106 To test our hypothesis, we quantified the expression of genes coding for the 107 mediators of cysteine metabolism (CDO, GCS and cystinosin), which are, 108 respectively, cysteine dioxygenase type I [CDO1 (19)], glutamate-cysteine ligase 109 catalytic subunit [GCLC (20)] and CTNS (21). Additionally, we quantified the 110 expression of the gene encoding the cystine/glutamate antiporter xCT (solute carrier 111 family 7 member 11, Slc7a11), a protein localized in the plasma membrane (22,23) 112 that is thus responsible for providing cells with cysteine (24). We also quantified the 113 expression of the gene Slc45a2 (solute carrier family 45 member 2), for which a 114 similar function in transporting cysteine to cells has been suggested (25). Lastly, we 115 quantified the expression of the main genes that regulate pheomelanin synthesis by 116 changing the intracellular concentration of cyclic adenosine monophosphate (cAMP) 117 and thus influence the intramelanosomal activity of tyrosinase, the key enzyme in the 118 melanogenesis pathway. These are the genes coding for the melanocortin 1 receptor 6 119 in the membrane of melanocytes [MC1R (26)] and peptides that bind to it and act as 120 their antagonists: agouti-signalling (ASIP) and agouti-related (AGRP) proteins (27). 121 The genes described above and their influence on cysteine metabolism and 122 pheomelanin synthesis are summarized in Figure 1. We investigated if the 123 expression of these genes is sensitive to increase in cysteine availability in a manner 124 that favors pheomelanin synthesis in melanocytes. To date, the genes that regulate 125 intramelanocytic cysteine transport to melanosomes (Figure 1) are unknown (11), but 126 the investigation of the genes considered here should reflect a potential favoring of 127 the genetic pathway to synthesis of pheomelanin in response to an increase in 128 cysteine uptake. Any potential increase in pheomelanin synthesis by feather 129 melanocytes should result in an increase of plumage color intensity, which reflects 130 the amount of pheomelanin deposited in feathers in our model species (28). We also 131 investigated if these potential effects on gene expression are mediated by changes in 132 RNA and DNA methylation. Recent developments in analytical methods have 133 unveiled a key role of internal modifications in mRNA mediated by N6- 134 methyladenosine (m6A) in the regulation

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    33 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us